News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,240 Results
Type
Article (39161)
Company Profile (282)
Press Release (648797)
Section
Business (203906)
Career Advice (1998)
Deals (35373)
Drug Delivery (89)
Drug Development (80857)
Employer Resources (168)
FDA (16102)
Job Trends (14811)
News (344656)
Policy (32450)
Tag
Academia (2530)
Alliances (49189)
Alzheimer's disease (1266)
Approvals (16067)
Artificial intelligence (146)
Bankruptcy (354)
Best Places to Work (11583)
Biotechnology (199)
Breast cancer (191)
Cancer (1392)
Cardiovascular disease (112)
Career advice (1665)
Cell therapy (285)
Clinical research (64729)
Collaboration (489)
Compensation (271)
COVID-19 (2542)
C-suite (109)
Data (1396)
Diabetes (177)
Diagnostics (6171)
Earnings (84908)
Employer resources (146)
Events (110067)
Executive appointments (404)
FDA (16801)
Funding (441)
Gene therapy (199)
GLP-1 (600)
Government (4333)
Healthcare (18709)
Infectious disease (2635)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16354)
Job creations (3625)
Job search strategy (1418)
Layoffs (420)
Legal (7864)
Lung cancer (201)
Lymphoma (99)
Manufacturing (207)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19206)
Metabolic disorders (461)
Neuroscience (1590)
NextGen Class of 2024 (6499)
Non-profit (4467)
Northern California (1722)
Obesity (262)
Opinion (184)
Patents (122)
People (56475)
Phase I (20135)
Phase II (28505)
Phase III (21250)
Pipeline (516)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (266)
Real estate (5891)
Regulatory (21697)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1477)
Startups (3562)
United States (15385)
Vaccines (564)
Weight loss (182)
Date
Today (4)
Last 7 days (158)
Last 30 days (1603)
Last 365 days (34525)
2025 (94)
2024 (35253)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37300)
Australia (6091)
California (3872)
Canada (1474)
China (323)
Colorado (173)
Connecticut (180)
Europe (79857)
Florida (548)
Georgia (136)
Illinois (389)
Indiana (227)
Maryland (640)
Massachusetts (2996)
Michigan (175)
Minnesota (296)
New Jersey (1123)
New York (1104)
North Carolina (746)
Northern California (1722)
Ohio (148)
Pennsylvania (940)
South America (1092)
Southern California (1477)
Texas (560)
Utah (108)
Washington State (403)
688,240 Results for "ivantis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
Sight Sciences, Inc. today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc.
April 29, 2024
·
6 min read
Policy
Glaukos Announces Settlement of Patent Litigation with Ivantis, Inc.
Ivantis to Pay $60 Million and Ongoing Double-Digit Royalty to Glaukos
September 15, 2021
·
5 min read
Deals
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
Alcon announced the closing of its previously announced acquisition of Ivantis®, developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.
January 10, 2022
·
9 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
TheoremRx Inc. Enters into Agreement for a Proposed Transaction
January 2, 2025
·
1 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Press Releases
BRIJ Medical, Inc. Awarded Breakthrough Technology Agreement in the Non-Invasive Skin Closure Category with Premier, Inc.
December 17, 2024
·
2 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
1 of 68,824
Next
